Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement April 28, 2025 Next Post Zweig Breadth Thrust Dominates the Headlines – But What about an Exit Strategy? April 28, 2025 Related Posts New Cannabis Consumption Trends, Regulatory Shifts Seen Driving Market in 2025 May 5, 2025 Hazer and KBR Enter Global Deal to Accelerate Licensing and Commerciali May 5, 2025 White Cliff Minerals Limited (ASX: WCN) – Trading Halt May 5, 2025